{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:41:51Z","timestamp":1770061311448,"version":"3.49.0"},"reference-count":27,"publisher":"Global Health and Education Projects, Inc","content-domain":{"domain":["mchandaids.org"],"crossmark-restriction":true},"short-container-title":["Int J MCH AIDS"],"abstract":"<jats:sec>\n                    <jats:title>Background and Objective<\/jats:title>\n                    <jats:p>Postpartum hemorrhage (PPH) remains a significant concern in crisis-affected contexts, where the implementation of heat-stable carbetocin (HSC) and tranexamic acid (TXA) for PPH prevention and treatment lacks evidence. This study aims to evaluate the effects of a capacity-strengthening package on the use of uterotonics for PPH prevention and detection, and the use of TXA for PPH treatment in basic maternity facilities in South Sudan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this implementation study, the six chosen facilities followed a stepwise sequence of PPH management: T1 (routine care), a transition period for package design; T2 (package without HSC and TXA); T3 (package and HSC); and T4 (package with HSC and TXA). The intervention comprised refresher training, an online provider community, PPH readiness kits, alarm bells, and displayed algorithms. The main outcomes were trends in prophylactic uterotonic use, including HSC, visual diagnosis of bleeding, and oxytocin and TXA use for PPH treatment. Analyses were adjusted for cluster effect and baseline characteristics. The study was registered in the Pan-African Clinical Trials Registry (PACTR202302476608339).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From February 1, 2022, to February 17, 2023, 3142 women were recruited. Nearly all women received prophylactic uterotonics across all four phases, with a significant increase after T3 (T4-T1: 100%\u201398%; 95% CI: 4.4\u20130.4). Oxytocin alone was the most used in T1 (98%) and T2 (94%) and HSC alone in T3 (87%) and T4 (82%) (T4-T1: 95% CI: 75.5\u201383.3). PPH diagnosis tripled from 1.2% of all births to 3.6% (T2-T1: 95% CI: 0.4\u20135.2) and stayed roughly at 3% in T3 and T4. For treatment, universal oxytocin use in T1 and T2 decreased in T3 upon HSC initiation (T3-T2: 27%\u2013100%; 95% CI: 95.5\u201349.9), whereas TXA use increased in T4 (T4-T1: 95%\u20130%; 95% CI: 54.6\u201399.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Global Health Implications<\/jats:title>\n                    <jats:p>An intervention package to improve the quality of PPH prevention and treatment can effectively increase HSC and TXA use in crisis settings. It could be scaled up in similar contexts with ongoing supervision to mitigate confusion between the existing and new medications, such as the reduced use of oxytocin for PPH treatment. Sustaining cold chain investments remain vital to ensure oxytocin quality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/ijma_8_2023","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T01:39:10Z","timestamp":1724981950000},"page":"S55-S63","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Postpartum Hemorrhage in Humanitarian Settings: Heat-Stable Carbetocin and Tranexamic Acid Implementation Study in South Sudan"],"prefix":"10.21106","volume":"13","author":[{"given":"Nguyen Toan","family":"Tran","sequence":"first","affiliation":[{"name":"Australian Center for Public and Population Health Research, Faculty of Health, University of Technology, Sydney, NSW, Australia"},{"name":"Faculty of Medicine, University of Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awatta Walter","family":"Ochan","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, South Sudan Country Office UN House, Juba, South Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemelia","family":"Sake","sequence":"additional","affiliation":[{"name":"South Sudan Nurses and Midwives Association, Juba College of Nursing and Midwifery, Juba, South Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okpwoku","family":"Sukere","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, South Sudan Country Office UN House, Juba, South Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willibald","family":"Zeck","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Technical Division, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Seuc","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, South Sudan Country Office UN House, Juba, South Sudan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catrin","family":"Schulte-Hillen","sequence":"additional","affiliation":[{"name":"United Nations Population Fund, Humanitarian Response Division, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8847","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"10.25259\/IJMA_8_2023\/ref-1","volume-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","author":"World Health Organization","year":"2012"},{"key":"10.25259\/IJMA_8_2023\/ref-2","volume-title":"Trends in maternal mortality 2000\u20132020: Estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA\/Population Division","author":"WHO, UNICEF, Bank W, Division UP","year":"2023"},{"issue":"1","key":"10.25259\/IJMA_8_2023\/ref-3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/GRF.0b013e3181cc406d","article-title":"Postpartum hemorrhage: Epidemiology, risk factors, and causes","volume":"53","author":"Oyelese","year":"2010","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"10.25259\/IJMA_8_2023\/ref-4","doi-asserted-by":"publisher","first-page":"CD007412","DOI":"10.1002\/14651858.CD007412.pub5","article-title":"Active versus expectant management for women in the third stage of labour","volume":"2","author":"Begley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.25259\/IJMA_8_2023\/ref-5","volume-title":"WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage","author":"World Health Organization","year":"2018"},{"key":"10.25259\/IJMA_8_2023\/ref-6","volume-title":"WHO Model Lists of Essential Medicines, 21st List 2019","author":"World Health Organization","year":"2019"},{"issue":"1","key":"10.25259\/IJMA_8_2023\/ref-8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12913-023-09263-4","article-title":"Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India","volume":"23","author":"Cook","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.25259\/IJMA_8_2023\/ref-9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1805489","article-title":"Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth","volume":"379","author":"Widmer","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.25259\/IJMA_8_2023\/ref-10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bpobgyn.2008.08.004","article-title":"Epidemiology of postpartum haemorrhage: A systematic review","volume":"22","author":"Carroli","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.25259\/IJMA_8_2023\/ref-11","doi-asserted-by":"publisher","first-page":"e3054","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: Systematic review and cumulative meta-analysis","volume":"344","author":"Ker","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.25259\/IJMA_8_2023\/ref-12","doi-asserted-by":"publisher","first-page":"CD004896","DOI":"10.1002\/14651858.CD004896.pub4","article-title":"Antifibrinolytic drugs for acute traumatic injury","volume":"2015","author":"Ker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10084","key":"10.25259\/IJMA_8_2023\/ref-13","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.25259\/IJMA_8_2023\/ref-14","doi-asserted-by":"publisher","first-page":"CD011689","DOI":"10.1002\/14651858.CD011689.pub3","article-title":"Uterotonic agents for preventing postpartum haemorrhage: A network meta-analysis","volume":"12","author":"Gallos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.25259\/IJMA_8_2023\/ref-15","doi-asserted-by":"publisher","first-page":"CD012964","DOI":"10.1002\/14651858.CD012964","article-title":"Antifibrinolytic drugs for treating primary postpartum haemorrhage","volume":"2","author":"Shakur","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.25259\/IJMA_8_2023\/ref-16","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/ijerph19073765","article-title":"Implementing heat-stable carbetocin for postpartum haemorrhage prevention in low-resource settings: A rapid scoping review","volume":"19","author":"Tran","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"10.25259\/IJMA_8_2023\/ref-17","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.3390\/ijerph19127385","article-title":"Tranexamic acid for postpartum hemorrhage treatment in low-resource settings: A rapid scoping review","volume":"19","author":"Tran","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.25259\/IJMA_8_2023\/ref-19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2303966","article-title":"Randomized trial of early detection and treatment of postpartum hemorrhage","volume":"389","author":"Gallos","year":"2023","journal-title":"N Engl J Med"},{"key":"10.25259\/IJMA_8_2023\/ref-23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13031-019-0247-4","article-title":"Health policy mapping and system gaps impeding the implementation of reproductive, maternal, neonatal, child, and adolescent health programs in South Sudan: A scoping review","volume":"14","author":"Belaid","year":"2020","journal-title":"Confl Health"},{"key":"10.25259\/IJMA_8_2023\/ref-24","doi-asserted-by":"publisher","first-page":"f6753","DOI":"10.1136\/bmj.f6753","article-title":"Implementation research: What it is and how to do it","volume":"347","author":"Peters","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.25259\/IJMA_8_2023\/ref-25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijgo.2015.06.047","article-title":"A mixed-methods study of barriers and facilitators to the implementation of postpartum hemorrhage guidelines in Uganda","volume":"132","author":"Braddick","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.25259\/IJMA_8_2023\/ref-26","article-title":"Package \u2018pwr\u2019","volume":"1","author":"Champely","year":"2018","journal-title":"R package version"},{"issue":"3","key":"10.25259\/IJMA_8_2023\/ref-27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2105\/ajph.94.3.361","article-title":"Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement","volume":"94","author":"Des Jarlais","year":"2004","journal-title":"Am J Public Health"},{"key":"10.25259\/IJMA_8_2023\/ref-28","doi-asserted-by":"publisher","first-page":"a2390","DOI":"10.1136\/bmj.a2390","article-title":"Improving the reporting of pragmatic trials: An extension of the CONSORT statement","volume":"337","author":"Zwarenstein","year":"2008","journal-title":"Bmj"},{"issue":"1","key":"10.25259\/IJMA_8_2023\/ref-29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-020-03485-8","article-title":"Uterotonics for prevention of postpartum haemorrhage: EN-BIRTH multi-country validation study","volume":"21","author":"Ruysen","year":"2021","journal-title":"BMC Pregnancy and Childbirth"},{"issue":"1","key":"10.25259\/IJMA_8_2023\/ref-30","first-page":"79","article-title":"Oxytocin infusion after oxytocin bolus and carbetocin bolus to reduce blood loss during and after cesarean section\u2014a randomized clinical trial","volume":"83","author":"Fahmy","year":"2015","journal-title":"Med J Cairo Univ"},{"issue":"6","key":"10.25259\/IJMA_8_2023\/ref-31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.11622\/smedj.2016107","article-title":"Postpartum blood loss: Visual estimation versus objective quantification with a novel birthing drape","volume":"57","author":"Lertbunnaphong","year":"2016","journal-title":"Singapore Med J"},{"issue":"3","key":"10.25259\/IJMA_8_2023\/ref-32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.AOG.0000137873.07820.34","article-title":"Estimating blood loss: Can teaching significantly improve visual estimation?","volume":"104","author":"Dildy","year":"2004","journal-title":"Obstet Gynecol"}],"container-title":["International Journal of Maternal and Child Health and AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/mchandaids.org\/management-of-postpartum-hemorrhage-in-humanitarian-settings-using-heat-stable-carbetocin-and-tranexamic-acid\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mchandaids.org\/management-of-postpartum-hemorrhage-in-humanitarian-settings-using-heat-stable-carbetocin-and-tranexamic-acid\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:24:04Z","timestamp":1770024244000},"score":1,"resource":{"primary":{"URL":"https:\/\/mchandaids.org\/index.php\/ijma\/article\/view\/90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":27,"alternative-id":["10.25259\/IJMA_8_2023"],"URL":"https:\/\/doi.org\/10.25259\/ijma_8_2023","relation":{},"ISSN":["2161-864X","2161-8674"],"issn-type":[{"value":"2161-864X","type":"electronic"},{"value":"2161-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"article-number":"S55"}}